Cite
Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States.
MLA
Liu, Albert Y., et al. “Phase 1 Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings in the United States.” Journal of the International AIDS Society, vol. 24, no. 6, June 2021, pp. 1–10. EBSCOhost, https://doi.org/10.1002/jia2.25747.
APA
Liu, A. Y., Dominguez Islas, C., Gundacker, H., Neradilek, B., Hoesley, C., van der Straten, A., Hendrix, C. W., Beamer, M., Jacobson, C. E., McClure, T., Harrell, T., Bunge, K., Devlin, B., Nuttall, J., Spence, P., Steytler, J., Piper, J. M., & Marzinke, M. A. (2021). Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States. Journal of the International AIDS Society, 24(6), 1–10. https://doi.org/10.1002/jia2.25747
Chicago
Liu, Albert Y, Clara Dominguez Islas, Holly Gundacker, Blazej Neradilek, Craig Hoesley, Ariane van der Straten, Craig W Hendrix, et al. 2021. “Phase 1 Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings in the United States.” Journal of the International AIDS Society 24 (6): 1–10. doi:10.1002/jia2.25747.